| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. | General Counsel | Employee Stock Option (right to buy) | 110,046 | 27 Oct 2025 | Direct | ||
| PhaseBio Pharmaceuticals Inc | SVP and General Counsel | Employee Stock Option (right to buy) | 87,500 | 24 Feb 2022 | Direct | ||
| MapLight Therapeutics, Inc. | General Counsel | Voting Common Stock | 27,098 | 27 Oct 2025 | Direct | ||
| PhaseBio Pharmaceuticals Inc | SVP and General Counsel | Restricted Stock Unit | 18,750 | 24 Feb 2022 | Direct | ||
| PhaseBio Pharmaceuticals Inc | SVP and General Counsel | Common Stock | 8,463 | 20 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MPLT | MapLight Therapeutics, Inc. | 27 Oct 2025 | 2 | $0 | 4 | General Counsel | 28 Oct 2025, 16:15 |
| MPLT | MapLight Therapeutics, Inc. | 25 Oct 2025 | 0 | $0 | 3 | General Counsel | 27 Oct 2025, 16:50 |
| /report/000116924522000076-hanson-kristopher-2022-05-20 | PhaseBio Pharmaceuticals Inc | 20 May 2022 | 1 | +$3,291 | 4 | SVP and General Counsel | 24 May 2022, 17:13 |
| /report/000116924522000007-hanson-kristopher-2022-02-24 | PhaseBio Pharmaceuticals Inc | 24 Feb 2022 | 2 | $0 | 4 | VP, Head of Legal | 28 Feb 2022, 18:19 |
| /report/000116924521000126-hanson-kristopher-2021-11-19 | PhaseBio Pharmaceuticals Inc | 19 Nov 2021 | 1 | +$3,105 | 4 | VP, Head of Legal | 23 Nov 2021, 17:51 |
| /report/000116924521000042-hanson-kristopher-2021-05-20 | PhaseBio Pharmaceuticals Inc | 20 May 2021 | 1 | +$3,046 | 4 | VP, Head of Legal | 24 May 2021, 18:09 |